3002.49.00.50/Dengue Tetravalent Vaccine/Germany

Dengue Tetravalent Vaccine from Germany

A chimeric live-attenuated tetravalent vaccine protecting against all four dengue virus serotypes for endemic prevention. Falls under HTS 3002.49.0050 as an 'other' vaccine for human prophylactic use, not matching specific viral listings. Developed through biotechnological recombination.

Duty Rate — Germany → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Secure FDA biologics import authorization; use validated -70°C shipping containers for live virus stability

• Label with serotype composition and expiration; submit CBER lot testing results pre-shipment

Dengue Tetravalent Vaccine from Germany — Import Duty Rate | HTS 3002.49.00.50